VCYT
VCYT clinical trials: VERACYTE, INC.
Every trial on ClinicalTrials.gov where VERACYTE, INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 8
- Trials linked
- 1
- As lead sponsor
- 7
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
VCYT on the catalyst calendar · VCYT registry changes
- Primary completion Dec 31, 2024Sponsor estimateNo phase registeredNCT06426628Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab ClassifierVeracyte, Inc. · Pulmonary Nodule, SolitaryRecruitingVCYTLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2028Sponsor estimateNo phase registeredNCT04396808Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate CancerUniversity of Michigan Rogel Cancer Center · Prostate CancerActive, not recruitingVCYTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2030Sponsor estimateNo phase registeredNCT02609269Decipher Genomics Resource for Intelligent DiscoveryGenomeDx Biosciences Corp · Prostate CancerEnrolling by invitationVCYTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 31, 2030Sponsor estimatePhase 2/Phase 3NCT06282588Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular TracersCancer Research Antwerp · Prostate CancerRecruitingVCYTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2028Sponsor estimatePhase 2NCT06990542Image-guided, Tumor-focused Radiotherapy Treatment in Intermediate and High-risk Prostate CancerUniversity of California, San Diego · Prostate CancerRecruitingVCYTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 15, 2030Sponsor estimateNo phase registeredNCT03769415Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCAUNC Lineberger Comprehensive Cancer Center · Breast CancerRecruitingVCYTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2028Sponsor estimateNo phase registeredNCT07282808Focal or Radical Therapy: a Lesion-based Molecular Evaluation in Prostate CancerSingapore General Hospital · Prostate CancerRecruitingVCYTCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2029Sponsor estimatePhase 3NCT06332274tislelizUMaB in canceR Patients With molEcuLar residuaL DiseaseGustave Roussy, Cancer Campus, Grand Paris · CancerRecruitingVCYTCollaboratorONCCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 8 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner